Granger, IN, United States of America

Julian R Pleasants


 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 1992-2001

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Julian R Pleasants

Introduction

Julian R Pleasants is a notable inventor based in Granger, Indiana, who has made significant contributions to the field of biomedical sciences. With a total of nine patents to his name, he has focused on developing innovative methods for treating tumors and producing monoclonal antibodies.

Latest Patents

Among his latest patents are methods for treating a tumor containing fibrin using a fibrin-specific monoclonal antibody and compositions used therein. This invention relates to a method for the production of monoclonal antibodies utilizing an immunized germ-free animal. The invention also provides methods for the use of such monoclonal antibodies, as well as polyclonal antibodies derived from an immunized germ-free animal, for both in vitro and in vivo clinical diagnostics and therapeutics. Additionally, he has developed methods for treating a fibrin-encapsulated tumor using a fibrin-specific monoclonal antibody and compositions used therein, further emphasizing his commitment to advancing medical treatments.

Career Highlights

Julian R Pleasants is currently associated with American Biogenetic Sciences, Inc., where he continues to innovate and contribute to the field. His work has been instrumental in the development of new therapeutic methods that have the potential to improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Paul E Gargan and Victoria A Ploplis, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

Julian R Pleasants exemplifies the spirit of innovation in the biomedical field, with his patents reflecting a dedication to improving clinical diagnostics and therapeutics. His contributions are paving the way for advancements in cancer treatment and antibody production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…